The Care Quality Commission
  • Doctor
  • Independent doctor

Health in Menopause

Overall: Good read more about inspection ratings

Quantum House. 3-5, College Street, Nottingham, NG1 5AQ (0115) 938 8828

Provided and run by:
Health in Menopause Limited

All Inspections

6 July 2023

During a monthly review of our data

We carried out a review of the data available to us about Health in Menopause on 6 July 2023. We have not found evidence that we need to carry out an inspection or reassess our rating at this stage.

This could change at any time if we receive new information. We will continue to monitor data about this service.

If you have concerns about Health in Menopause, you can give feedback on this service.

14 April 2022

During a routine inspection

This service is rated as Good overall.

The key questions are rated as:

Are services safe? – Good

Are services effective? – Good

Are services caring? – Good

Are services responsive? – Good

Are services well-led? – Good

We carried out an announced comprehensive inspection at Health in Menopause on 14 April 2022. This is the first time this service has been inspected by the Care Quality Commission (CQC) following its registration as a new service in July 2020.

Health in Menopause is a private menopause clinic in Nottingham. The service provides consultations, treatment and advice by an experienced doctor specialising in the treatment of menopause symptoms. The service offers face to face, online and telephone appointments to women across the East Midlands and beyond.

Dr Alice Duffy is a sole trader, the only director, General Practitioner (GP) and the CQC registered manager. A registered manager is a person who is registered with the CQC to manage the service. Registered persons have legal responsibility for meeting the requirements in the Health and Social Care Act 2008 and associated Regulations about how the service is run.

We reviewed feedback provided by 62 patients on the providers website before our inspection and during our onsite visit we saw surveys that were analysed on a three monthly basis.

Our key findings were:

  • We found evidence to uphold the provision of safe care and treatment. Procedures for medicines management were robust to support online prescribing and ongoing monitoring.
  • The provider worked within evidence-based guidance, whilst providing individualised care, and the provider was British Menopause Society trained.
  • There was an established programme of quality improvement and clinical audit to demonstrate the efficacy of patient outcomes.
  • There were proactive communication channels with the patients’ registered NHS GPs to ensure continuity of care.
  • We found that the service was caring and compassionate towards patients and we observed many positive comments received from those who had used the service.
  • The service was easily available and accessible for this dedicated patient group, including information freely available on the providers website.
  • We found that the service had strong leadership from an experienced, committed and patient-centred clinical provider.
  • The service sought support with all aspects of governance through appropriate dedicated menopause associations and expert peers.

The areas where the provider should make improvements are:

  • The provider should source feedback on the quality of clinical care patients received and any improvements in health.

  • The provider should ensure they have records that provide assurance that the defibrillator is regularly checked by the owner of the building.

  • The provider should embed the new vision and values statement with a strategy to monitor achievement.

Dr Rosie Benneyworth BM BS BMedSci MRCGP
Chief Inspector of Primary Medical Services and Integrated Care